Literature DB >> 4136767

Hepatitis B antigen: antigenic sites related to human serum proteins revealed by affinity chromatography.

A R Neurath, A M Prince, A Lippin.   

Abstract

Hepatitis B antigen-associated particles, isolated from sera of antigen carriers, were submitted to affinity chromatography on columns of insolubilized antibodies to normal human plasma. The particles adsorbed to the immunosorbent at pH 7.2 and were subsequently eluted at pH 2.2. Exposure of the particles to 8 M urea, 5 M KI, pH 2.2, detergents, organic solvents, or proteolytic enzymes failed to prevent their subsequent adsorption to the immunosorbent. This suggests that antigenic determinants related to human plasma proteins are constituent components of hepatitis B antigen-associated particles. These determinants are distinct from the group-specific (a) and subtype-specific (d or y) sites of the hepatitis B antigen and appear to be related to antigenic specificities on prealbumin, albumin, apolipoproteins C and D, and the gamma-chain of immunoglobulin G.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4136767      PMCID: PMC388527          DOI: 10.1073/pnas.71.7.2663

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Particles associated with Australia antigen in the sera of patients with leukaemia, Down's Syndrome and hepatitis.

Authors:  M E Bayer; B S Blumberg; B Werner
Journal:  Nature       Date:  1968-06-15       Impact factor: 49.962

2.  A serum antigen (Australia antigen) in Down's syndrome, leukemia, and hepatitis.

Authors:  B S Blumberg; B J Gerstley; D A Hungerford; W T London; A I Sutnick
Journal:  Ann Intern Med       Date:  1967-05       Impact factor: 25.391

3.  Stability of the lipid and protein of hepatitis-associated (Australia) antigen.

Authors:  C Y Kim; D M Bissell
Journal:  J Infect Dis       Date:  1971-05       Impact factor: 5.226

4.  Electron microscopy of herpes simplex virus. IV. Studies with ferritin-conjugated antibodies.

Authors:  S Nii; C Morgan; H M Rose; K C Hsu
Journal:  J Virol       Date:  1968-10       Impact factor: 5.103

5.  Virus-like particles in serum of patients with Australia-antigen-associated hepatitis.

Authors:  D S Dane; C H Cameron; M Briggs
Journal:  Lancet       Date:  1970-04-04       Impact factor: 79.321

6.  An antigen detected in the blood during the incubation period of serum hepatitis.

Authors:  A M Prince
Journal:  Proc Natl Acad Sci U S A       Date:  1968-07       Impact factor: 11.205

7.  Isolation and characterization of human chyle chylomicrons and lipoproteins.

Authors:  P Alaupovic; R H Furman; W H Falor; M L Sullivan; S L Walraven; A C Olson
Journal:  Ann N Y Acad Sci       Date:  1968-11-21       Impact factor: 5.691

8.  Observations on Australia antigen in Japanese.

Authors:  K Okochi; S Murakami
Journal:  Vox Sang       Date:  1968       Impact factor: 2.144

9.  Rheumatoid factor and Australia antigen.

Authors:  J F Ziegenfuss; J Miller; D Rossman
Journal:  N Engl J Med       Date:  1971-05-13       Impact factor: 91.245

10.  Electrn microscopic observations on virus-like particles associated with SH antigen.

Authors:  P T Jokelainen; K Krohn; A M Prince; N D Finlayson
Journal:  J Virol       Date:  1970-11       Impact factor: 5.103

View more
  10 in total

1.  Cell-mediated immunity in guinea pigs to subunits derived from hepatitis B surface antigen.

Authors:  G A Cabral; R Chairez; F Marciano-Cabral; M Suarez; G R Dreesman; J L Melnick; F B Hollinger
Journal:  Infect Immun       Date:  1975-09       Impact factor: 3.441

2.  Antibodies to glutaraldehyde-polymerized human albumin (anti-pHSA) in viral hepatitis.

Authors:  D E Sansonno; P Detomaso; G Leone; G Bufano; R Rizzi; O G Manghisi
Journal:  Dig Dis Sci       Date:  1989-09       Impact factor: 3.199

3.  Activity of nucleic acid polymers in rodent models of HBV infection.

Authors:  Katrin Schöneweis; Neil Motter; Pia L Roppert; Mengji Lu; Baoju Wang; Ingo Roehl; Dieter Glebe; Dongliang Yang; John D Morrey; Michael Roggendorf; Andrew Vaillant
Journal:  Antiviral Res       Date:  2017-11-08       Impact factor: 5.970

4.  Relationship of large hepatitis B surface antigen polypeptide to human serum albumin.

Authors:  J W Shih; P L Tan; J L Gerin
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

5.  Production of antibody to individual polypeptides derived from purified hepatitis B surface antigen.

Authors:  G R Dreesman; R Chairez; M Suarez; F B Hollinger; R J Courtney; J L Melnick
Journal:  J Virol       Date:  1975-09       Impact factor: 5.103

Review 6.  The hepatitis B virus and its DNA polymerase: the prototype three-D virus.

Authors:  S Z Hirschman
Journal:  Mol Cell Biochem       Date:  1979-07-15       Impact factor: 3.396

7.  Mechanisms responsible for defective human T-lymphocyte sheep erythrocyte rosette function associated with hepatitis B virus infections.

Authors:  F V Chisari; J A Routenberg; T S Edgington
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

Review 8.  Prophylactic vaccination against hepatitis B: achievements, challenges and perspectives.

Authors:  Wolfram H Gerlich
Journal:  Med Microbiol Immunol       Date:  2014-12-19       Impact factor: 3.402

9.  Interaction of hepatitis B surface antigen (Australia antigen) with membrane vesicles of Pseudomonas aeruginosa.

Authors:  L K Weng; M E Bayer; W T London
Journal:  Infect Immun       Date:  1975-07       Impact factor: 3.441

10.  Host specificity of a serum marker for hepatitis B: evidence that "e antigen" has the properties of an immunoglobulin.

Authors:  A R Neurath; N Strick
Journal:  Proc Natl Acad Sci U S A       Date:  1977-04       Impact factor: 11.205

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.